| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/29/2004 | EP1028961B1 Pleuromutilin derivatives as antimicrobials |
| 09/29/2004 | EP1000059B1 Tricyclic vasopressin agonists |
| 09/29/2004 | CN1533390A Drugs containing triazaspiro [5,5] undecane derivatives as the active ingredient |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1532198A Quaternary chelidonine derivatives |
| 09/29/2004 | CN1168728C Pyrrolo-isoquinoline and tetrahydropyrrolko-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 09/29/2004 | CN1168727C Substituted benzimidazole |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168716C Optical active tetrahydrobenzindole derivatives |
| 09/28/2004 | US6797825 Protein kinase inhibitors |
| 09/28/2004 | US6797718 Ether substituted imidazopyridines |
| 09/28/2004 | US6797717 Acyl coenzyme a cholesterol acyltransferase (acat) inhibitors |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/28/2004 | US6797715 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them |
| 09/28/2004 | US6797714 Hypoglycemic agents; antidiabetic agents; side effect reduction |
| 09/28/2004 | US6797709 Sexual disorders |
| 09/28/2004 | US6797259 Delivery of muscle relaxants through an inhalation route |
| 09/25/2004 | CA2423388A1 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 09/23/2004 | WO2004081009A1 Quinazoline derivatives as tgf-beta inhibitors |
| 09/23/2004 | WO2004081008A1 Novel fused triazolones and the uses thereof |
| 09/23/2004 | WO2004081007A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 09/23/2004 | WO2004080976A1 Phthalazinone derivatives |
| 09/23/2004 | WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080402A2 Potassium salt of an hiv integrase inhibitor |
| 09/23/2004 | WO2004080398A2 1-amino 1h-imidazoquinolines |
| 09/23/2004 | WO2004080390A2 Antiprotozoal imidazopyridine compounds |
| 09/23/2004 | WO2004043913A3 Hetero-substituted benzimidazole compounds and antiviral uses thereof |
| 09/23/2004 | WO2004021989A3 Imidazolopyridines and methods of making and using the same |
| 09/23/2004 | WO2004005472A3 Inhibitors of ftsz and uses thereof |
| 09/23/2004 | US20040186295 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 09/23/2004 | US20040186292 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186153 Pharmaceutical use of N-carbamoylazole derivatives |
| 09/23/2004 | US20040186140 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186132 Steroid receptor modulator compounds and methods |
| 09/23/2004 | US20040186130 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | US20040186129 2-Aroylimidazole compounds for treating cancer |
| 09/23/2004 | US20040186128 Amide substituted imidazopyridines |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186124 Anticarcinogenic agents, antitumor agents treating cancer of breast, head , neck, gastrointestinal or stomach, leukemia, ovaries, bronchi, lung or pancreas |
| 09/23/2004 | US20040186107 Diazabicyclic central nervous system active agents |
| 09/23/2004 | US20040186106 such as (S)-N-{{(1R, 2R)-2-{4-{[2-(4-Methyl-piperazin-1-yl)-benzimidazol-1-yl]methyl}-phenyl}-cyclohex-1-yl} carbonyl}-phenylglycinamide; for treatment of ischemic brain disorders |
| 09/23/2004 | US20040186094 Substituted pyridoindoles as serotonin agonists and antagonists |
| 09/23/2004 | US20040185008 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 09/23/2004 | US20040185007 heating layers containing drugs such as benztropine, pergolide, ropinirole, amantadine and deprenyl on solid supports, to produce vapors, then condensing to aerosols which can be delivered by breathing; drug delivery method and devices |
| 09/23/2004 | US20040185006 Delivery of stimulants through an inhalation route |
| 09/23/2004 | US20040185005 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 09/23/2004 | US20040185004 Delivery of erectile dysfunction drugs through an inhalation route |
| 09/23/2004 | US20040185002 condensation aerosol for delivery of a drug selected from chlordiazepoxide, betahistine, clonidine, testosterone, a conjugated estrogen, an estrogen ester, estradiol, an estradiol ester, ethinyl estradiol, an ethinyl estradiol ester and hyoscyamine |
| 09/23/2004 | US20040185001 Delivery of physiologically active compounds through an inhalation route |
| 09/23/2004 | US20040185000 Delivery of antihistamines through an inhalation route |
| 09/23/2004 | US20040184999 Delivery of anti-migraine compounds through an inhalation route |
| 09/23/2004 | US20040184998 Delivery of drug esters through an inhalation route |
| 09/23/2004 | US20040184997 volatilizing a coating of drug on a solid support, having the surface texture of a metal foil, to a temperature sufficient to produce a heated vapor of drug and condensing the heated vapor to form condensation aerosol particles |
| 09/23/2004 | US20040184996 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 09/23/2004 | DE10311300A1 New 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols, useful as total or selective herbicides and pesticides, e.g. insecticides, acaricides and nematocides for plant protection |
| 09/23/2004 | CA2519107A1 Novel fused triazolones and the uses thereof |
| 09/23/2004 | CA2517655A1 1-amino 1h-imidazoquinolines |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP1460073A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460072A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/22/2004 | EP1460067A1 Bicyclic derivative, process for producing the same, and use |
| 09/22/2004 | EP1459753A1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments |
| 09/22/2004 | EP1459743A2 Agent for prophylaxis and treatment of glaucoma |
| 09/22/2004 | EP1459742A2 Agent for prophylaxis and treatment of asthenopia and pseudomyopia |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1458720A1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 09/22/2004 | EP1458719A1 Pyridoquinoxaline antivirals |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 09/22/2004 | EP1458395A1 New use |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1379527B1 Epindolidione pigments |
| 09/22/2004 | EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
| 09/22/2004 | EP1100781B1 High affinity ligands for nociceptin receptor orl-1 |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP0966468B1 Crown ether-derivatised perylenes |
| 09/22/2004 | EP0914321B1 Indole derivatives for the treatment of osteoporosis |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531540A Heterocyclic compounds and cerebral function improvers containing same as active |
| 09/22/2004 | CN1531537A Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1530107A Insulin resistance treatment by growth hormone secretory hormone |
| 09/22/2004 | CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/22/2004 | CN1167420C Azabanzimidazole-based compounds for modulating serine/threonine protein kinase function |
| 09/21/2004 | US6794509 Compounds for fluorescence labeling |
| 09/21/2004 | US6794404 Viral polymerase inhibitors |
| 09/21/2004 | US6794398 Preventive/remedies for liver diseases |